A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Hemophilia & Sickle Cell Bookmark and Share

Hemophilia and Sickle Cell Program

The Hemophilia and Sickle Cell Program at City of Hope provides care to children, adolescents and young adults (AYA) with inherited coagulation disorders, such as hemophilia and red blood cell disorders like sickle cell anemia. We are a regional referral center for these disorders and provide support to hospitals and physicians locally, nationally and internationally.

Our hemophilia and sickle cell program has earned Center of Excellence designations from California Children’s Services, and we are one of approximately 145 federally funded comprehensive Hemophilia Treatment Centers (HTCs) in the U.S. We bring together a multidisciplinary team of doctors, nurses and other health professionals experienced in treating children with inherited coagulation disorders and red blood cell disorders. We provide comprehensive care for infants, children, adolescents and young adults with:
 
  • Hemophilia and Von Willebrand disease
  • Platelet abnormalities, including idiopathic thrombocytopenic purpura (ITP), other thrombocytopenias and platelet dysfunction
  • Disorders of hemostasis and thrombosis
  • Red blood cell abnormalities, including sickle cell anemia and iron deficiency
  • Non-malignant hematologic disorders
  • Bone marrow and neutrophil disorders, including aplastic anemia, storage diseases and neutropenia
     
For patients with hemophilia and other inherited coagulation disorders, we provide consultations to hematologists and oncologists, pediatricians, pediatric surgeons, dentists and ob/gyns. Our areas of expertise include:
 
  • Inhibitors in hemophilia A and B
  • Risk factors for and prevention of inhibitor formation
  • Early diagnosis of inhibitors
  • Treatment of bleeding in patients with inhibitors
  • Prophylaxis to prevent bleeding and preserve joint health
  • Inhibitor eradication using Immune Tolerance Induction (ITI)
     
For patients with sickle cell disease and other red blood cell disorders, our emphasis is on preventing disease-related and treatment-related complications. We work to ensure that pain is adequately managed so that patients can maintain a good quality of life. We also work closely with the City of Hope Hematopoietic Cell Transplantation Program.
 
Given the hereditary nature of these conditions, we offer genetic testing, including carrier testing and counseling. We meet with the family after diagnosis to discuss the chances of having other children with a blood disorder, and we educate children in an age-appropriate manner.

Our program offers both medical treatment and psychosocial support to young patients and their family members. Our medical team collaborates to develop an effective, individualized treatment plan, while professionals in nursing; psychology; social work; physical, occupational and recreational therapy; and school re-integration provide individual attention and group activities for patients and their families.
 
The pediatric comprehensive care team for the hemophilia and the sickle cell programs includes:

Our physicians and scientists are leading research to find better treatments for patients with inherited blood disorders. For more information on our pediatric hematology research, including ongoing clinical trials, visit City of Hope’s Clinical Trials Online website.
 

Hemophilia & Sickle Cell

Hemophilia and Sickle Cell Program

The Hemophilia and Sickle Cell Program at City of Hope provides care to children, adolescents and young adults (AYA) with inherited coagulation disorders, such as hemophilia and red blood cell disorders like sickle cell anemia. We are a regional referral center for these disorders and provide support to hospitals and physicians locally, nationally and internationally.

Our hemophilia and sickle cell program has earned Center of Excellence designations from California Children’s Services, and we are one of approximately 145 federally funded comprehensive Hemophilia Treatment Centers (HTCs) in the U.S. We bring together a multidisciplinary team of doctors, nurses and other health professionals experienced in treating children with inherited coagulation disorders and red blood cell disorders. We provide comprehensive care for infants, children, adolescents and young adults with:
 
  • Hemophilia and Von Willebrand disease
  • Platelet abnormalities, including idiopathic thrombocytopenic purpura (ITP), other thrombocytopenias and platelet dysfunction
  • Disorders of hemostasis and thrombosis
  • Red blood cell abnormalities, including sickle cell anemia and iron deficiency
  • Non-malignant hematologic disorders
  • Bone marrow and neutrophil disorders, including aplastic anemia, storage diseases and neutropenia
     
For patients with hemophilia and other inherited coagulation disorders, we provide consultations to hematologists and oncologists, pediatricians, pediatric surgeons, dentists and ob/gyns. Our areas of expertise include:
 
  • Inhibitors in hemophilia A and B
  • Risk factors for and prevention of inhibitor formation
  • Early diagnosis of inhibitors
  • Treatment of bleeding in patients with inhibitors
  • Prophylaxis to prevent bleeding and preserve joint health
  • Inhibitor eradication using Immune Tolerance Induction (ITI)
     
For patients with sickle cell disease and other red blood cell disorders, our emphasis is on preventing disease-related and treatment-related complications. We work to ensure that pain is adequately managed so that patients can maintain a good quality of life. We also work closely with the City of Hope Hematopoietic Cell Transplantation Program.
 
Given the hereditary nature of these conditions, we offer genetic testing, including carrier testing and counseling. We meet with the family after diagnosis to discuss the chances of having other children with a blood disorder, and we educate children in an age-appropriate manner.

Our program offers both medical treatment and psychosocial support to young patients and their family members. Our medical team collaborates to develop an effective, individualized treatment plan, while professionals in nursing; psychology; social work; physical, occupational and recreational therapy; and school re-integration provide individual attention and group activities for patients and their families.
 
The pediatric comprehensive care team for the hemophilia and the sickle cell programs includes:

Our physicians and scientists are leading research to find better treatments for patients with inherited blood disorders. For more information on our pediatric hematology research, including ongoing clinical trials, visit City of Hope’s Clinical Trials Online website.
 
Patient Care Overview

City of Hope Locations

Faces of Cancer

Meet City of Hope patients and their families.
 
 
Clinics/Treatments/Services
As a Comprehensive Cancer Center – the highest designation given by the National Cancer Institute – we are widely regarded as a leader in cancer prevention and treatment.

Cancer Expertise Matters


NEWS & UPDATES
  • The outlook and length of survival has not changed much in the past 25 years for patients suffering from an aggressive form of pancreatic cancer known as pancreatic ductal adenocarcinoma (PDAC). These patients still have few options for therapy; currently available therapies are generally toxic and do not incre...
  • “With bladder cancer, the majority of patients that I see can be cured,” said urologist Kevin Chan, M.D., head of reconstructive urology at City of Hope. “The challenge is to get patients the same quality of life that they had before surgery.” To meet this challenge, Chan and the urologic team at City of Hope [...
  • Already pioneers in the use of immunotherapy, City of Hope researchers are now testing the bold approach to cancer treatment against one of medicine’s biggest challenges: brain cancer. This month, they will launch a clinical trial using patients’ own modified T cells to fight advanced brain tumors. One of but a...
  • Brain cancer may be one of the most-frightening diagnoses people can receive, striking at the very center of who we are as individuals. Further, it often develops over time, causing no symptoms until it’s already advanced. Listen to City of Hope Radio as Behnam Badie, M.D., director of the Brain Tumor Pro...
  • The whole is greater than the sum of its parts. It takes a village. No man is an island. Choose your aphorism: It’s a simple truth that collaboration usually is better than isolation. That’s especially true when you’re trying to introduce healthful habits and deliver health care to people at risk of disease and...
  • When Maryland Governor Larry Hogan announced earlier this week that he has the most common form of non-Hodgkin lymphoma, he was giving voice to the experience of more than 71,000 Americans each year. The announcement came with Hogan’s promise to stay in office while undergoing aggressive treatment for the...
  • The spine can be affected by many different kinds of tumors. Malignant, or cancerous, tumors can arise within the spine itself. Secondary spinal tumors, which are actually much more common, begin as cancers in another part of the body, such as the breast and prostate, and then spread, or metastasize, to the spi...
  • Although most cancer occurs in older adults, the bulk of cancer research doesn’t focus on this vulnerable and fast-growing population. City of Hope and its Cancer and Aging Research Team aim to change that, and they’re getting a significant boost from Professional Practice Leader Peggy Burhenn, R.N....
  • Liz Graef-Larcher’s first brain tumor was discovered by accident six years ago. The then-48-year-old with a long history of sinus problems and headaches had been sent for an MRI, and the scan found a lesion in her brain called a meningioma – a tumor that arises in the meninges, the layers of tissue that cover a...
  • The colon and rectum are parts of the body’s gastrointestinal system, also called the digestive tract. After food is digested in the stomach and nutrients are absorbed in the small intestine, the remaining material moves down into the lower large intestine (colon) where water and nutrients are absorbed. The low...
  • If there is one truism about hospital stays it is that patients want to get out. For many, however, the joy of being discharged is tempered by the unexpected challenges that recovery in a new setting may pose. Even with professional help, the quality of care and treatment that patients receive at City of Hope [...
  • Jana Portnow, M.D., associate director of the Brain Tumor Program at City of Hope, didn’t expect to specialize in treating brain tumors. But, early in her career, she undertook a year of research on pain management and palliative care and, in that program, got to know many patients with brain tumors. After that...
  • Ask any patient: Nurses are as pivotal in their care as doctors. They answer the call of a patient in the middle of the night, they hold the patient’s hand as he or she takes on yet another round of treatment and, in the best-case scenario, they wave goodbye as the patient leaves the hospital, […]
  • Many oncologists, not to mention their patients, might think that there’s no place for mathematical analysis in the treatment of cancer. They might think that all treatment decisions are based on unique factors affecting individual patients, with no connection to other patients and their treatment regimen...
  • Within three days in 2007, Stephanie Hosford, then 37, learned that she was pregnant with her long-awaited second child – and that she had triple-negative breast cancer. Soon afterward, Hosford discovered that she and her husband, Grant, had been approved to adopt a little girl from China.  After encountering m...